Biodesix’ Proteomic Analysis of Innovative Immunotherapy Clinical Trial in Pancreas Cancer presented at European Society of Medical Oncology’s (ESMO) World Congress on Gastrointestinal Cancer
The first presentation of data resulting from a corporate partnership to explore development of a new diagnostic test based on Biodesix’ technology.